Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
about
Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children.Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity.Protective effect of the Japanese traditional medicine juzentaihoto on myelosuppression induced by the anticancer drug TS-1 and identification of a potential biomarker of this effect.Proteomic changes in the heart of diet-induced pre-diabetic mice.Plasma biomarkers of mouse agingDifferential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.Decreased insulin sensitivity and increased oxidative damage in wasting adipose tissue depots of wild-type miceNovel serum protein biomarkers indicative of growth hormone doping in healthy human subjectsQualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.Heterogeneity among white adipose tissue depots in male C57BL/6J mice.Plasma biomarker proteins for detection of human growth hormone administration in athletes.Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats.
P2860
Q33776670-EC850B36-87CB-48D1-9D8B-A394B7B8E723Q33817041-59F70059-B56B-4BAC-8598-C46ACBDA16A2Q34372789-7028F025-EE38-4B10-9566-43CAC0F6EEBAQ34847102-6DBD1055-6ACE-474F-86C7-A96D0F4477F9Q35201170-735EC85A-1E82-4EFD-93A0-D7D765E46CAAQ35223038-82F2AC21-DED0-4E29-9BA7-96317AF72792Q35223799-83FCE0E6-143A-47E1-ABA9-E20D4095E609Q36253119-9FCA328B-EBFB-454B-B34A-3EBCA0C85940Q36453050-AAE38685-DAED-4ADB-9EB7-A55940311544Q36795884-27F0494B-C465-4877-9544-614A07EAF0FDQ37202283-245327C2-9B5A-4776-A115-10D355153C46Q38697831-DE5A4618-CA16-438A-A224-3B601BD76BE3Q38893130-E0187570-EE3E-4676-B4E8-7FA51A886A9EQ41139336-B2FE8D23-7EEE-4750-B2BF-A33A64A5382EQ41565757-9542D40A-B3DA-4DB4-A70A-459717C2BFADQ46349954-0BC9234E-531A-4E41-A902-A6B4EBBE1DF9Q47878327-42BC8814-7932-45D9-A83F-B7F27D512940
P2860
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Activation of the GH/IGF-1 axi ...... nges in normal adult subjects.
@en
type
label
Activation of the GH/IGF-1 axi ...... nges in normal adult subjects.
@en
prefLabel
Activation of the GH/IGF-1 axi ...... nges in normal adult subjects.
@en
P2093
P2860
P1476
Activation of the GH/IGF-1 axi ...... anges in normal adult subjects
@en
P2093
John J Kopchick
Lawrence A Frohman
P2860
P304
P356
10.1016/J.GHIR.2009.03.001
P577
2009-04-21T00:00:00Z